CytoRecovery
PrivateLast Round
Accelerator
Jun 3, 2024
Total Funding Raised
$1.55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CytoRecovery is a biotechnology company that develops microfluidic technology designed to recover biological cells from samples.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CytoRecovery Comparables
Compare CytoRecovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| On-chip Biotechnologies Co., Ltd. | 85% | |
| LevitasBio | 83% | |
| NanoCellect Biomedical | 81% |
CytoRecovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 3, 2024 | ||||
| Grant | Feb 9, 2023 | ||||
| Seed | Dec 1, 2022 | ||||
| Convertible Debt | Apr 22, 2019 | ||||
| Pre Seed | Oct 19, 2018 |
CytoRecovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Virginia LVG Seed Fund | Seed |
| Common Wealth Angels | Convertible Debt, Seed |
| Virginia Innovation Partnership Corporation | Convertible Debt |
| The Launch Place | Pre Seed, Seed |
| BioTools Innovator | Accelerator |
| Bloomfield Partners | Convertible Debt, Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 31% MoM, from 1.5K to 2K.
- Jul 20, 2026
Open roles increased from 0 to 4, representing 80% of headcount.
CytoRecovery Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CytoRecovery's valuation, stock price, and market status.
Is CytoRecovery a public or private company?
CytoRecovery is a private company.
What is the current stock price of CytoRecovery?
CytoRecovery is a private company with no public stock price. No recent secondary market data is available.
How much is CytoRecovery worth (valuation)?
Valuation information for CytoRecovery is not publicly available.
Can I buy CytoRecovery stock?
CytoRecovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CytoRecovery's last funding round?
CytoRecovery's most recent funding round was Accelerator on June 3, 2024.
Who are the main investors in CytoRecovery?
Key investors in CytoRecovery include The Launch Place.
Will CytoRecovery IPO soon?
No public IPO plans have been announced for CytoRecovery.
How can I track CytoRecovery secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CytoRecovery's secondary market activity and sign up for updates.